U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

ZANTHOXYLUM SCHINIFOLIUM WHOLE

MORE DETAILS

M8QGZ6O788

structurally diverse
Status:
Possibly Marketed Outside US
Source:
PAMO Kill Natural by GeoRim Pharmaceutical
(2013)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aefdfa17-2cd1-4964-93d6-2ffbdebe11df
First approved in 2012
Source:
Bone Care by Evercarepharm Co., Ltd
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59b1fa7b-1ffa-4da7-a900-86de1adf450e
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966